DL, N., GM, G., BR, S., AG, L., J, B., SP, B., . . . CY, C. (2020). SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood. Nature communications, 11(1), 4698. https://doi.org/10.1038/s41467-020-18468-8
Chicago Style (17th ed.) CitationDL, Ng, et al. "SARS-CoV-2 Seroprevalence and Neutralizing Activity in Donor and Patient Blood." Nature Communications 11, no. 1 (2020): 4698. https://doi.org/10.1038/s41467-020-18468-8.
MLA (9th ed.) CitationDL, Ng, et al. "SARS-CoV-2 Seroprevalence and Neutralizing Activity in Donor and Patient Blood." Nature Communications, vol. 11, no. 1, 2020, p. 4698, https://doi.org/10.1038/s41467-020-18468-8.
Warning: These citations may not always be 100% accurate.